Opening ceremony of research project approved by Guangzhou Health and Family
Planning Commission was held in St. Stamford Modern Cancer Hospital Guangzhou.
On Feb. 26, 2016, applied by St. Stamford Modern Cancer HospitalGuangzhou, the research project comparing
efficacy and safety between treatments of combining nanoknife with gemcitabine
and radiotherapy with gemcitabine for local pancreatic cancer, was approved by Guangzhou
Health and Family Planning Commission. In the afternoon of Dec. 5 St.
Stamford Modern Cancer Hospital Guangzhou gave the opening report of the
research project with the participation and guidance of Prof. Xu Meng, chief
physician and doctoral supervisor of the first clinical medicine college of Jinan
University and organizer of biological treatment committee of Guangdong anticancer
association, and presence of Tu Xiaoming, vice president of Singapore
St.Stamford International Medical Group, and Wang Huaizhong, dean of St.
Stamford Modern Cancer Hospital Guangzhou, together with other leaders and
research groups.
Members of the
research project initiation consultation committee
In the ceremony, Huang Deliang, oncology inpatient department director of St.
Stamford Modern Cancer Hospital Guangzhou, gave the theme report to the project
comparing efficacy and safety between
treatments of combining nanoknife with gemcitabine and radiotherapy with
gemcitabine. The subject of the research is to compare the local ablation
efficacy of nanoknife, when combined with current well-acknowledged effective
treatment of gemcitabine, with combination of gemcitabine with other therapies,
and assess their safety to serve better clinical application. This project is,
verified by Guangzhou intelligence institute, an initiative research project at
home and abroad and also a breakthrough in pancreatic cancer treatment.
Huang Deliang,
executor of the research project
Then the research group held a heated discussion over main content and
feasibility of the research, focusing on the expected effect of combining
gemcitabine with nanoknife technology at its 100% efficacy in treating
pancreatic cancer. Associated director of oncology department and doctoral
supervisor, Prof. Wang Xin, pointed out, as long as pancreatic cancer patients treated
by the joint treatment of nanoknife and gemcitabine survive longer than the
control group, the research is testified successful, so just keep calm during
the process. Meanwhile, the research group also conducted analysis and
discussion on every detail of the research process to guarantee the final
success.
On the scene of the opening ceremony of the research project
In the end, Prof. Xu Meng gave
his comments and instruction on the research project, which according to him is
research on precision medicine and ranks in advanced research
fields. He stressed study index detailing and safety during the research, expecting
a formation of the hospital’s own clinical treatment guidelines based on 30
cases of joint treatment of nanoknife and gemcitabine. He hoped the research
group can steadily conducts this project, with high-end technology of nanoknife
as a platform and pancreatic cancer treatment as a start, to establish a
characteristic treatment of high-end nanoknife technology combined with other
therapies. He believed, with pancreatic cancer as the first target, it will
cover more cancers and benefit more cancer patients.
Tu Xiaoming, Vice
president of Singapore St.Stamford International Medical Group,
During the opening report, Tu Xiaoming, Vice president of
Singapore St.Stamford International Medical Group, said it’s not easy to get the
government's approval for a research project, but St.Stamford Modern Cancer
Hospital Guangzhou has successfully passed two research project initiations.
Besides the mentioned project, the
other one was research on the feasibility
of cryotherapy in triple-negative breast cancer recurrence and metastasis,
applied by director Dai Wenyan. These indicated the hospital’s new level in
technical innovation and overall improvement on academic and research ability.
The opening report aroused extensive social attention.
Direct link:
没有评论:
发表评论